Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Erin Christensen et al.|Cancer Research|2009Cited by 248
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphomaAndrew G. Polson, Allen Ebens, Shang‐Fan Yu et al.|Blood|2007Cited by 172